Showing results (391-400 of 404) with videos related to

Sort By:
Pageof 41
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPSScott W Woods, Sophie Parker, Melissa J Kerr, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia ProgramNora Penzel, Pablo Polosecki, Jean Addington, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.
Schizophrenia Bulletin Open|July 16, 2026
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for PsychosisHeather M Wastler, Aubrey Moe, Alexandra M Blouin, et al.
Early Intervention in Psychiatry|August 29, 2023
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPSScott W Woods, Sophie Parker, Melissa J Kerr, et al.
Schizophrenia Bulletin Open|August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia ProgramJean Addington, Amy Shalev, Lu Liu, et al.
Schizophrenia Bulletin Open|August 27, 2025
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia ProgramJean Addington, Lu Liu, Monica Chu, et al.
Schizophrenia (Heidelberg, Germany)|October 15, 2025
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiativeZarina R Bilgrami, Eduardo Castro, Carla Agurto, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia ProgramJean Addington, Lu Liu, Amy Braun, et al.
Schizophrenia Bulletin|May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-SchizophreniaHenry R Cowan, Danielle Pratt, Jai L Shah, et al.
Pageof 41